Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Princeton Bancorp, Inc. (BPRN)
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
$43.98-1.19%
Close 2026-11-05 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.83 → 3.90 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BPRN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Increase cash from operating activities above $5 million | Operating income recovered to $8.05 million in 2026-Q1. | Improving | cash from operating activities falls below $5 million in any quarter | Cash from operations: $2.613M FY2026-Q2; GAAP. Published target: >= $5 million. The stored target says 2026-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 7, 20262,613,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a regional financial business with a mixed, rather than clearly durable, multi-year setup. The thesis is in a watch state: the latest quarter missed, recent earnings surprises have been erratic, and financial performance is below its industry group.
The valuation evidence points to BPRN being cheap versus peers, with a moderate gap between expectations and the evidence snapshot’s model view. However, valuation has risen recently, while company momentum fell sharply; the priced-in signal is labeled unjustified, but overall fragility is rated low.
Near term, the latest earnings miss and uneven surprise history leave results vulnerable, while the next guidance update is an important check. In the multi-year view, Q3 loan and deposit growth and a reported year-over-year reduction in funding costs support the business, but revenue comparisons are mixed and execution quality remains fragile. The announced dividend increase is a concrete capital-return step, though the evidence does not establish its longer-term consistency.
The near-term thesis weakens if management cuts guidance or if rate cuts weigh on the financial sector. It gains support if sector peers continue to report strong earnings and raise guidance. Over the multi-year view, the central question is whether loan and deposit growth can translate into steadier performance while funding costs are managed.
For the next 1 to 3 years, BPRN’s thesis rests on turning recent balance-sheet growth into more consistent results; the latest miss and fragile earnings quality keep the setup uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Princeton Bancorp keeps paying a steady dividend of $0.35 per share. |
| Intact |
| dividend per share falls below $0.35 in any quarter |
Dividend per share: $0.35 per share FY2026-Q2; GAAP. Published target: >= $0.35 per share. The stored target says 2026-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 7, 20260.35 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 3 supplied quarters. Management reported: “President/CEO Edward Dietzler spoke to the quarter results, "We are pleased with our strong second quarter performance, which reflects the continued execution of our strategic priorities and the resilience of our franchise.” Delivery assessment Nov 4, 2026 |
Sustain operating income near $8 million | Operating income recovered to $8.05 million in 2026-Q1. | Intact | operating income falls below $7 million in any quarter | Operating income: $9.183M FY2026-Q2; GAAP. Published target: >= $7 million. The stored target says 2026-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 7, 20269,183,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.79 → $3.90 · observed estimates
$0.08B → $0.09B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.79 | $83,732,000 | 3 / 2 |
| 2026-07-25 | $3.79 | $83,732,000 | 3 / 2 |
| 2026-07-26 | $3.79 | $83,732,000 | 3 / 2 |
| 2026-07-27 | $3.79 | $83,732,000 | 3 / 2 |
| 2026-07-28 | $3.79 | $83,732,000 | 3 / 2 |
| 2026-07-29 | $3.79 | $83,732,000 | 3 / 2 |
| 2026-07-30 | $3.81 | $83,732,000 | 3 / 2 |
| 2026-07-31 | $3.81 | $83,732,000 | 3 / 2 |
| 2026-08-01 | $3.81 | $93,457,000 | 2 / 2 |
| 2026-08-02 | $3.83 | $82,364,000 | 3 / 2 |
| 2026-08-03 | $3.83 | $82,364,000 | 3 / 2 |
| 2026-08-04 | $3.83 | $82,364,000 | 3 / 2 |
| 2026-08-05 | $3.83 | $82,364,000 | 3 / 2 |
| 2026-08-06 | $3.83 | $82,364,000 | 3 / 2 |
| 2026-08-07 | $3.83 | $92,139,000 | 2 / 1 |
| 2026-08-08 | $3.83 | $82,364,000 | 3 / 2 |
| 2026-08-09 | $3.83 | $82,364,000 | 3 / 2 |
| 2026-08-10 | $3.83 | $82,364,000 | 3 / 2 |
| 2026-08-11 | $3.83 | $82,364,000 | 3 / 2 |
| 2026-08-12 | $3.83 | $82,364,000 | 3 / 2 |
| 2026-08-13 | $3.83 | $92,139,000 | 2 / 1 |
| 2026-08-14 | $3.83 | $92,139,000 | 2 / 1 |
| 2026-08-15 | $3.83 | $92,139,000 | 2 / 1 |
| 2026-08-16 | $3.83 | $92,139,000 | 2 / 1 |
| 2026-08-17 | $3.83 | $92,139,000 | 2 / 1 |
| 2026-08-18 | $3.83 | $92,139,000 | 2 / 1 |
| 2026-08-19 | $3.83 | $92,139,000 | 2 / 1 |
| 2026-08-20 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-08-21 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-08-22 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-08-23 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-08-24 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-08-25 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-08-26 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-08-27 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-08-28 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-08-29 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-08-30 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-08-31 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-01 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-02 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-03 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-04 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-05 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-06 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-07 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-08 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-09 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-10 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-11 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-12 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-13 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-14 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-15 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-16 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-17 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-18 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-19 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-20 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-21 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-22 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-23 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-24 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-25 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-26 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-27 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-28 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-29 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-09-30 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-01 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-02 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-03 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-04 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-05 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-06 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-07 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-08 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-09 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-10 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-11 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-12 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-13 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-14 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-15 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-16 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-17 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-18 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-19 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-20 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-21 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-22 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-23 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-24 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-25 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-26 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-27 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-28 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-29 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-30 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-10-31 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-11-01 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-11-02 | $3.83 | $92,139,000 | 2 / 2 |
| 2026-11-03 | $3.85 | $92,139,000 | 2 / 2 |
| 2026-11-04 | $3.90 | $92,139,000 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.